Turning on hormone tap could aid osteoporosis fight

A potential new drug that 'opens the taps' for the release of useful hormones could stimulate new bone growth – and may eventually bring relief to osteoporosis sufferers.

The exciting potential of so-called negative allosteric modulators will be put under the microscope at a special symposium at The Federation of European Pharmacological Societies (EPHAR) 2008 Congress at The University of Manchester, UK, today (Wednesday, July 16).

European pharmacologists meeting in Manchester will present work that focuses on the stimulation of parathyroids – tiny glands located above the thyroids that control the release of the parathyroid (PTH) hormone into the bloodstream.

When the concentration of calcium is too low in the blood's plasma, PTH is released and acts on various tissues to increase the level of calcium in the blood. This calcium then activates the calcium sensing receptor on the parathyroid cell, which then reduces PTH release.

The first POSITIVE allosteric modulator was recently introduced into clinical practice for treating patients displaying high levels of PTH in the plasma – such as those with chronic kidney disease on dialysis and those displaying hypercalcaemia with parathyroid cancer. It mimics the effect of calcium on the receptor and so reduces PTH release.

But now attention is switching to NEGATIVE allosteric modulators, which have been shown in pre-clinical trials to block the effect of calcium on the parathyroid cell and thus increase the release of PTH in the serum.

"Daily administration of a negative allosteric modulator of the calcium sensing receptor should promote a sustained increase of PTH in such a way that it will stimulate new bone formation," said symposium organiser Martial Ruat, a neuropharmacologist at the government funded Centre National de la Recherche Scientifique in France.

"Now clinical trials will have to demonstrate the effectiveness and suitability of negative allosteric modulators for treating osteoporosis in humans."

While pharmacologists are excited and encouraged by results so far, Dr Ruat says it will be at least another eight to 10 years before negative allosteric modulators are passed for use in patients "Osteoporosis is a complex disease and the timescale might be rather long," says Dr Ruat, who is himself carrying out research to learn more about the potential benefits of both negative and positive allosteric modulators.

He added: "The calcium sensing receptor is also found in the kidney, the intestine, in some vascular and bone cells and also in the brain. We still need to identify the roles of this receptor in these tissues before being able to specify novel applications of these drugs."

Negative and positive allosteric modulators are also being studied by European pharmacologists with a view to identifying the functions of calcium sensing receptors in the control of blood pressure.

Source: University of Manchester

Related stories:

Drug lowers body's 'set point' to control hyperparathyroidism in dialysis patients
A medication called cinacalcet—an important part of treatment to control high levels of parathyroid hormone (PTH) in patients receiving dialysis for end-stage renal disease (ESRD)—works by resetting the balance between calcium and PTH levels, according to a study in the November Journal of the American Society of Nephrology (JASN).
Dietary approaches to stop hypertension
I was doing what any self-respecting dietitian does with friends at the beach ... reading the label on the corn chip bag. I was surprised that this particular brand was lower in sodium than other snack foods I've seen.
Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
Essential for life in higher animals, vitamin D, once linked to only bone diseases such as rickets and osteoporosis, is now recognized as a major player in contributing to overall human health, emphasizes UC Riverside's Anthony Norman, an international expert on vitamin D.
Low voltage current to stimulate growth of coral off South Florida coast
The thunderclaps and lightning flashes of Victor Frankenstein's laboratory seem far removed from the sunshine, hotels and snorkelers of the South Florida coast. But the town of Lauderdale-by-the-Sea is pursuing the dream of using electricity to help generate life.
Elderly turtle pair fails to produce offspring
(AP) -- She's around 80 years old. He's 100. Breathless scientists watched as the world's most endangered turtles successfully mated.
Soy foods aid bone density
Bone loss commonly occurs as we age, especially for women. Until recently, women were routinely prescribed estrogen after menopause to prevent bone loss and fractures.
Discovery of a type of aerosols from Sahara which will be useful to study climate change
Scientists of the Soil Science and Geopharmacy Research Group of the University of Granada (Spain), directed by Rafael Delgado, have discivered and characterized a new type of atmospheric aerosols named 'iberulites', which could be useful for the study of relevant atmospheric reactions from Earth.
Scientists Find Cells Coordinate Gene Activity with FM Bursts
(PhysOrg.com) -- How a cell achieves the coordinated control of a number of genes at the same time, a process that's necessary for it to regulate its own behavior and development, has long puzzled scientists.

News discussion:

Medicine & Health news